CTKB Buybacks
8 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–8; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| Cytek Biosciences, Inc. | 2026-03-31 | Reported repurchase cash | $0.00 |
| Cytek Biosciences, Inc. | 2025-12-31 | Reported repurchase cash | -$34,000.00 |
| Cytek Biosciences, Inc. | 2025-03-31 | Reported repurchase cash | $10.63M |
| Cytek Biosciences, Inc. | 2024-12-31 | Reported repurchase cash | $6.99M |
| Cytek Biosciences, Inc. | 2024-09-30 | Reported repurchase cash | $11.9M |
| Cytek Biosciences, Inc. | 2024-06-30 | Reported repurchase cash | $2.7M |
| Cytek Biosciences, Inc. | 2024-03-31 | Reported repurchase cash | $0.00 |
| Cytek Biosciences, Inc. | 2023-12-31 | Reported repurchase cash | $34.6M |